Blistex acquires Stri-Dex acne line, Dairy Ease brand from Bayer.
This article was originally published in The Tan Sheet
Executive Summary
BLISTEX ADDING $20 MIL. STRI-DEX ACNE BRAND to its OTC business, the company announced March 11. The purchase of the Stri-Dex acne treatment line from Bayer's Consumer Care division gives Oakbrook, Ill.-based Blistex an 8.1% dollar share, or a fourth-place slot, in the $254 mil. combined acne remedy market in U.S. food, drug and mass merchandise outlets, according to Information Resources Inc. data for the 52 weeks ended Jan. 28.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning